Disclosure Panels Details Page
Melanoma Panel - Disclosures as of 10/17/2021
| Panel Member | Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty for Panel Member or Dependent | Spouse/Domestic Partner/Dependent Potential Conflict | Date Completed |
|---|---|---|---|---|---|---|
| Mark Albertini MD | Apeiron Biologics, Vienna, Austria Array BioPharma Inc, Boulder, CO Bristol-Myers Squibb Company Merck & Co., Inc. Nektar Therapeutics |
None | None | None | NA | 07/11/2021 |
| Christopher Barker MD | Alpha Tau Medical Amgen Inc. Elekta EMD Serono Merck & Co., Inc. Physical Sciences Incorporated (through subcontracted funds from NIH) |
Regeneron Pharmaceuticals, Inc. | None | None | NA | 06/21/2021 |
| Joel Baumgartner MD | None | None | None | None | NA | 09/21/2021 |
| Marian Birkeland PhD | None | None | None | None | NA | 05/21/2021 |
| Genevieve Boland MD,PhD | InterVenn Biosciences Olink Proteomics Palleon Pharmaceuticals Takeda Pharmaceuticals North America, Inc. |
Ankyra InterVenn Biosciences Merck & Co., Inc. Nektar Therapeutics Novartis Pharmaceuticals Corporation |
Novartis Pharmaceuticals Corporation | Ankyra | NA | 10/11/2021 |
| Bartosz Chmielowski MD,PhD | Advenchen Laboratories Aeglea Biotherapeutics Array Biopharma Ascentage Atreca Bristol-Myers Squibb Company Compugen Daiichi- Sankyo Co. Eli Lilly and Company EMD Serono Genentech, Inc. IDEAYA Biosciences Idera Immunocore Infinity Pharmaceuticals, Inc InstilBio Iovance Karyopharm Therapeutics Macrogenics Merck & Co., Inc. Nektar Therapeutics Neon Therapeutics Novartis Pharmaceuticals Corporation Oncosec PACT Pharma RAPT Therapeutics Replimune Tolero Pharmaceuticals Xencor |
Genentech, Inc. IDEAYA Iovance Biotherapeutics Nektar Therapeutics Oncosec |
None | None | NA | 05/26/2021 |
| Eileen Cucinotta | None | None | None | None | NA | 09/14/2021 |
| Dominick DiMaio MD | None | None | None | None | NA | 09/07/2021 |
| Alison Durham MD | OncoSec Medical Incorporated | None | None | None | NA | 07/27/2021 |
| Ryan Fields MD | None | None | None | None | NA | 07/25/2021 |
| Martin Fleming MD,FACS | None | None | None | None | NA | 08/01/2021 |
| Anjela Galan MD | None | None | None | None | NA | 06/22/2021 |
| Brian Gastman MD | Alkermes NIT |
Iovance | Castle Biosciences Quest Imaging |
Cutaneous Malignancies: A Surgical Perspective 1st Edition | NA | 06/02/2021 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | NA | 08/22/2021 |
| Samantha Guild JD | None | Melanoma Research Program (CDMRP) State of Texas |
None | None | NA | 06/14/2021 |
| Evelyn Handel PharmD,BCPS,BCOP | None | None | None | None | NA | 09/12/2021 |
| Ashley Holder MD | None | None | None | None | NA | 10/07/2021 |
| John Hyngstrom MD | None | Nektar Therapeutics | None | None | NA | 07/12/2021 |
| Douglas Johnson MD,MSCI | None | None | Bristol-Myers Squibb Company Catalyst Biopharma Iovance Janssen Pharmaceutica Products, LP Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec Pfizer Inc. |
None | NA | 08/26/2021 |
| Richard Joseph MD | Bristol-Myers Squibb Company | sanofi-aventis U.S. | None | None | NA | 10/04/2021 |
| Giorgos Karakousis MD | Merck & Co., Inc. | None | None | None | NA | 10/02/2021 |
| Ann Karosas RPh,BCOP | None | None | None | None | NA | 09/15/2021 |
| Kari Kendra MD,PhD | Amgen Inc. Karyopharm Therapeutics Merck & Co., Inc. Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | None | NA | 07/26/2021 |
| Maija Kiuru MD,PhD | None | None | None | None | NA | 07/17/2021 |
| Madeline Koch BSN,RN,OCN | None | None | None | None | NA | 08/24/2021 |
| Rashmi Kumar PhD | None | None | None | None | NA | 06/01/2021 |
| Julie Lange MD,ScM | None | None | None | None | NA | 09/11/2021 |
| Ryan Lanning MD,PhD | None | None | None | None | NA | 09/30/2021 |
| Miguel Materin MD | None | Castle Biosciences | Carl Zeiss Meditec | None | NA | 07/05/2021 |
| Nicole McMillian MS | None | None | None | None | NA | 06/29/2021 |
| Mai Nguyen PhD | None | None | None | None | NA | 09/22/2021 |
| Anthony Olszanski MD,RPh | None | Bristol-Myers Squibb Company Eisai Inc. Merck & Co., Inc. Pfizer Inc. sanofi-aventis U.S. |
None | None | NA | 06/21/2021 |
| Patrick Ott MD,PhD | AstraZeneca Pharmaceuticals LP Bristol-Myers Squibb Company Celldex Therapeutics Cytomx Genentech, Inc. Gilead Sciences, Inc. MedImmune Inc. Merck & Co., Inc. Oncorus Pfizer Inc. Xencor |
Celldex Therapeutics Merck & Co., Inc. Novartis Pharmaceuticals Corporation Roche Laboratories, Inc. |
None | None | NA | 03/23/2021 |
| Donna Powell DHSc,CMD,RT(T) | None | None | None | None | NA | 07/12/2021 |
| Kumar Rao MD | HARK Vision | None | None | None | NA | 09/27/2021 |
| Ramesh Rengan MD,PhD | None | AstraZeneca Pharmaceuticals LP Gilead Sciences, Inc. Ion Beam Applications |
None | None | NA | 07/18/2021 |
| Merrick Ross MD | Amgen Inc. | Amgen Inc. Merck & Co., Inc. |
Amgen Inc. | None | NA | 06/07/2021 |
| April Salama MD | Bristol-Myers Squibb Company Immunocore Merck & Co., Inc. Nektar Therapeutics |
Iovance Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmaceuticals, Inc. |
None | None | NA | 07/07/2021 |
| Rohit Sharma MD | None | None | None | None | NA | 06/21/2021 |
| Joseph Skitzki MD | None | None | None | None | NA | 06/27/2021 |
| Jeffrey Sosman MD | None | Array Bristol-Myers Squibb Company Nektar Therapeutics |
None | None | NA | 10/04/2021 |
| Susan Swetter MD | None | None | None | None | NA | 07/08/2021 |
| John Thompson MD | Calithera Pharmaceuticals | AVEO Pharmaceuticals, Inc. Bristol-Myers Squibb Company Iovance pharmaceuticals Regeneron Pharmaceuticals, Inc. |
None | None | NA | 10/09/2021 |
| Katy Tsai MD | Bristol-Myers Squibb Company Genentech, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Oncosec Pfizer Inc. Replimune |
Regeneron Pharmaceuticals, Inc. | Genzyme Corporation | None | NA | 06/15/2021 |
| Evan Wuthrick MD | None | None | None | None | NA | 07/01/2021 |